OXYGEN USE IN PHYSICAL THERAPY PRACTICE. Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR

Similar documents
What is the next best step?

10/17/2016 OXYGEN DELIVERY: INDICATIONS AND USE OF EQUIPMENT COURSE OBJECTIVES COMMON CAUSES OF RESPIRATORY FAILURE

Non-Invasive Ventilation

NON-INVASIVE VENTILATION. Lijun Ding 23 Jan 2018

NON INVASIVE LIFE SAVERS. Non Invasive Ventilation (NIV)

Condensed version.

POLICY. Number: Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE. Authorization

Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.

Indications for Respiratory Assistance. Sheba Medical Center, ICU Department Nick D Ardenne St George s University of London Tel Hashomer

Oxygen and Oxygen Equipment

BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012

Oxygen and Oxygen Equipment

Noninvasive Mechanical Ventilation in Children ศ.พญ.อร ณวรรณ พฤทธ พ นธ หน วยโรคระบบหายใจเด ก ภาคว ชาก มารเวชศาสตร คณะแพทยศาสตร โรงพยาบาลรามาธ บด

Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients

Recent Advances in Respiratory Medicine

Oxygen and Oxygen Equipment

Airway Clearance Devices

Keeping Patients Off the Vent: Bilevel, HFNC, Neither?

County of Santa Clara Emergency Medical Services System

NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity

OSA and COPD: What happens when the two OVERLAP?

BiLevel Pressure Device

(To be filled by the treating physician)

Up to 50% of continuous flow oxygen therapy patients experience clinically significant nocturnal desaturation. 1

5. What is the cause of this patient s metabolic acidosis? LACTIC ACIDOSIS SECONDARY TO ANEMIC HYPOXIA (HIGH CO LEVEL)

By Mark Bachand, RRT-NPS, RPFT. I have no actual or potential conflict of interest in relation to this presentation.

Noninvasive ventilation: Selection of patient, interfaces, initiation and weaning

Acute NIV in COPD and what happens next. Dr Rachael Evans PhD Associate Professor, Respiratory Medicine, Glenfield Hospital

NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)

Oxygen: Is there a problem? Tom Heaps Acute Physician

Basics of NIV. Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC. Consultant, Critical Care Medicine Medanta, The Medicity

Understanding Breathing Muscle Weakness

Mechanical Ventilation Principles and Practices

Non-invasive Ventilation

MEDICAL POLICY SUBJECT: HOME AND COMMUNITY OXYGEN THERAPY

11/20/2015. Beyond CPAP. No relevant financial conflicts of interest. Kristie R Ross, M.D. November 12, Describe advanced ventilation options

Hypoventilation? Obstructive Sleep Apnea? Different Tests, Different Treatment

Identification and Treatment of the Patient with Sleep Related Hypoventilation

MEDICAL POLICY SUBJECT: HOME AND COMMUNITY OXYGEN THERAPY

Paramedic Rounds. Pre-Hospital Continuous Positive Airway Pressure (CPAP)

Prepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor

PedsCases Podcast Scripts

High Flow Oxygen Therapy in Acute Respiratory Failure. Laurent Brochard Toronto

NIV use in ED. Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH

INDICATIONS FOR RESPIRATORY ASSISTANCE A C U T E M E D I C I N E U N I T P - Y E A R M B B S 4

Charisma High-flow CPAP solution

Julie Zimmerman, MSN, RN, CCRN Clinical Nurse Specialist

I. Subject: Pressure Support Ventilation (PSV) with BiPAP Device/Nasal CPAP

Monitoring: gas exchange, poly(somno)graphy or device in-built software?

Clinical Policy: Oxygen Therapy in the Home Reference Number: CP.MP.485

Objectives. Health care significance of ARF 9/10/15 TREATMENT OF ACUTE RESPIRATORY FAILURE OF VARIABLE CAUSES: INVASIVE VS. NON- INVASIVE VENTILATION

Respiratory Failure in the Pediatric Patient

Oxygen Therapy: When, What and Why

MANAGING COPD AT HOME. Karla Schlichtmann, RRT

Lecture Notes. Chapter 2: Introduction to Respiratory Failure

RESPIRATORY FAILURE. Dr Graeme McCauley KGH

Learning Objectives. 1. Indications versus contra-indications 2. CPAP versus NiVS 3. Clinical evidence

Oxygen and ABG. Dr Will Dooley

Competency Title: Continuous Positive Airway Pressure

RESPIRATORY FAILURE - CAUSES, CLINICAL INFORMATION, TREATMENT AND CODING CONVENTIONS

Approach to type 2 Respiratory Failure

Emergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE

Chronic Obstructive Pulmonary Disease (COPD) Copyright 2014 by Mosby, an imprint of Elsevier Inc.

Non-invasive Ventilation protocol For COPD

BiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT

Concerns and Controversial Issues in NPPV. Concerns and Controversial Issues in Noninvasive Positive Pressure Ventilation

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

ETCO2 MONITORING NON-INTUBATED PATIENTS

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Capnography. Capnography. Oxygenation. Pulmonary Physiology 4/15/2018. non invasive monitor for ventilation. Edward C. Adlesic, DMD.

Capnography 101. James A Temple BA, NRP, CCP

Disclosure. Learning Objectives. Bernadette Zelaya, RRT. Area Clinical Manager

How to write bipap settings

Evaluation of Effect of Breathe Ventilation System on Work of Breathing in COPD patients. Matthew Cohn, M.D.

A study of non-invasive ventilation in acute respiratory failure

IMPORTANCE OF DISASTER PLANNING

Challenging Cases in Pediatric Polysomnography. Fauziya Hassan, MBBS, MS Assistant Professor Pediatric Pulmonary and Sleep

Respiratory Management of Facioscapulohumeral Muscular Dystrophy. Nicholas S. Hill, MD Tufts Medical Center Boston, MA

Oxygenation. Chapter 45. Re'eda Almashagba 1

Causes and Consequences of Respiratory Centre Depression and Hypoventilation

Policy Specific Section: October 1, 2010 January 21, 2013

Nasal High Flow Humidification with or without Oxygen for COPD Management. Shereen Bailey, RCP, RRT, NPS

Haut debit nasal ou BiPAP? Laurent Brochard Toronto

Lumis Tx: the all-in-one hospital ventilation solution

Appendix E Choose the sign or symptom that best indicates severe respiratory distress.

NI 60. Non-invasive ventilation without compromise. Homecare Pneumology Neonatology Anaesthesia. Sleep Diagnostics Service Patient Support

a. Will not suppress respiratory drive in acute asthma

WHAT DO YOU WANT FROM A HOME VENTILATION SYSTEM? 8322_RS_HomeNIV_brochure_v14.ind1 1 4/7/06 12:57:35

Mechanical Ventilation ศ.พ.ญ.ส ณ ร ตน คงเสร พงศ ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร ศ ร ราชพยาบาล

Surgery Grand Rounds. Non-invasive Ventilation: A valuable tool. James Cromie, PGY 3 8/24/09

Home Pulse Oximetry for Infants and Children

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv

Neuromuscular diseases (NMDs) include both hereditary and acquired diseases of the peripheral neuromuscular system. They are diseases of the

CPAP. Pre-Hospital Treatment Using The Respironics Whisperflow CPAP Device. Charlottesville Albemarle Rescue Squad - CPAP

Chapter 11: Respiratory Emergencies

Interdisciplinary Care of the Patient with Amyotrophic Lateral Sclerosis Respiratory Therapy Care

Acute noninvasive ventilation what s the evidence? Respiratory Medicine Update: Royal College of Physicians & BTS Thu 28 th January 2016

Transcription:

OXYGEN USE IN PHYSICAL THERAPY PRACTICE Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR

Supplemental Oxygen Advantages British Medical Research Council Clinical Trial Improved survival using oxygen 15 hrs/day compared to using no oxygen in patients with PaO2 <55 mm Hg Improved survival did not appear until after 500 days of oxygen use The Nocturnal Oxygen Therapy Trial (NOTT) Survival is better in COPD/chronic stable hypoxemic patients who use oxygen 12-15 hrs/day Survival best by using nearly continuous O2

Supplemental Oxygen Advantages NOTT: Using nocturnal oxygen therapy (NOT) and continuous oxygen therapy (COT) improved brain function at 6 months NOTT: Using COT improved brain function at 1 year

Cumulative Survival % 100 90 80 70 60 50 40 30 20 203 subjects randomized to continuous or 12 hours of oxygen for at least 12 months NOTT 19 hrs MRC 12 hrs 15 hrs 87 subjects randomized to oxygen 15 hours/day or none No Oxygen 10 0 0 10 20 30 40 50 60 70 80 Time (months) Composite slide NOTT and MRC studies

Oxygen Prescription and Use FDA states: medical oxygen is defined as a prescription drug which requires a prescription in order to be dispensed except.for emergency use

APTA Statement Regarding Oxygen APTA is unaware of any regulations that prohibit the use of oxygen for patient management if it is prescribed and if parameters set by the physician are maintained. APTA Guide to Physical Therapist Practice (2 nd ed): supplemental oxygen listed as procedural intervention within the scope of P.T. practice under Prescription, Application, and, as appropriate, Fabrication of Devices and Equipment (supportive device) to improve ventilation and respiration/gas exchange

APTA Statement Regarding Oxygen Pharmacology in Physical Therapist Practice House Of Delegates (HOD) P06-04-14-14 Physical therapist patient/client management integrates an understanding of a patient s prescription and nonprescription medication regimen with consideration of its impact upon health, impairments, functional limitations, and disabilities. The administration and storage of medications used for physical therapy interventions is also a component of patient management and thus within the scope of physical therapist practice. Physical therapy interventions that may require the concomitant use of medications include, but are not limited to, agents that: Facilitate airway clearance and/or ventilation and respiration

Co-morbidities: Why are more patients needing supplemental oxygen? Older patients Multiple medical diagnoses Pulmonary diagnoses are increasing in incidence and prevalence

What are the advantages of Supplemental Oxygen? Oxygen during Exercise: 1)Decreases SOB 2)Decreases dynamic hyperinflation 3)Prolongs exercise tolerance 4)Improves sleep and mood 5)Increases mental alertness and stamina 6)Prevents/delays heart failure in severe lung disease

Pulse oximeters Oxygen Equipment

Oxygen Systems Oxygen Concentrator Stationary Portable

Oxygen tanks Oxygen Equipment

Choosing the Appropriate Delivery Device Nasal Cannula High Flow Nasal Cannula Oxymizer Venti-mask Partial Re-breather mask Non Re-breather mask Mask plus nasal cannula

Oxygen delivery devices Nasal Cannula Pendulum Reservoir (oxymizer) Nasal cannula:.25-6 LPM (22-45% FiO2) Oxymizer: 4 to ~10 LPM Nasal Reservoir (oxymizer)

Principles of Nasal Cannula Use Avoid using standard nasal cannula > 6 Liters Membranes within nasal passages become dry, irritated Switch to different delivery source: high flow cannula, mask Amount of oxygen flowing from oxygen source is always 100%

Oxygen Devices High Flow Nasal Cannula Conserving device Soft nasal prongs Tube diameter slightly larger Green connector tubing Use up to 15 LPM Provides ~ 1 Liter more than regulator setting

Oxygen Devices

Venti-Mask Settings

Partial Re-breather Mask

Oxygen Devices

Non-Rebreather Oxygen Mask

**Alternately** Physicians may prescribe maintenance of a specific oxygen saturation (SpO 2 ) level during rest and activity: maintain SpO 2 > % (usually 88%-90%) --PTs may titrate oxygen flow to maintain patients at or above this threshold saturation value Knowledge of Indications for Oxygen and How to Administer Physicians often specify flow rate in orders Deviations from prescribed dosages require an updated order from the physician

Compressed gas cylinders Oxygen ABC s

Liquid oxygen being discontinued Oxygen ABC s

Oxygen concentrators Oxygen ABC s

Portable Oxygen Concentrator AC, DC, and battery operation 5-20 lbs. Continuous (up to 3 LPM) Intermittent (up to 6 LPM) Airplane travel OK Battery life variable

Continuous flow vs Pulsed dose flow Oxygen ABC s

How to use a tank Oxygen ABC s

Guidelines and Titrating Flows to Match Needs during Different Activities Flows may be different at rest, exercise, and sleep What if your patient is a Carbon Dioxide (CO2) retainer? Flows are different for various pulmonary diagnoses Pulmonary Therapy can determine this over time

Carbon Dioxide Retention Normal PCO2 = 35-45 mmhg In long-standing COPD and Cystic Fibrosis, PCO2 is chronically high, often > 45 mmhg Over time, the metabolic system of these patients learns to accommodate for consistently high CO2 levels These patients do not react by going into Acute Respiratory Failure The ph level is compensated and within normal range

CO2 Retention Fact: In healthy individuals, respiratory drive is stimulated by an increase in CO2 levels (Increase RR to blow off extra CO2) CO2 and O2 levels in the blood are detected by several structures within the vasculature Aortic bodies Carotid bodies

In long-standing COPD and CF, due to consistently high CO2, the body becomes sensitive to Oxygen levels rather than CO2 levels as a stimulus to increase or decrease RR In some cases, too much supplemental oxygen (higher liter flow) can blunt the stimulus to maintain an adequate RR Clinical S & S: somnolence, confusion, lack of rise of SpO2 when increase FiO2 CO2 Retention

Oxygen Logistics Patient provides his/her oxygen or will you provide? Oxygen storage Cost/billing Prescription from MD Pulse Oximetry

Common Oxygen-Related Questions/Comments Will I be able to get off of my oxygen? I ll just slow down my exercise so I won t have to wear oxygen. Is oxygen addictive? Can I smoke while I wear my oxygen? My food doesn t taste as good since I started wearing oxygen. I don t want to wear oxygen when I m in public. I wear my oxygen after I get back from the mailbox because I am so out of breath.

Non-Invasive Ventilation

Definition Non-invasive ventilation (NIV) refers to the provision of ventilatory support through the patient's upper airway using a mask or similar device. This technique is distinguished from those which bypass the upper airway with a tracheal tube, laryngeal mask, or tracheostomy and are considered invasive

Negative Pressure Ventilation Drinker-Shaw iron lung Late 1920 s Used to treat poliomyelitis

Using a mask Positive Pressure NIV Decreased respiratory rate Decrease in dyspnea Decreased hypercapnia Decreased work of breathing Increased tidal volume Rests the diaphragm Improved oxygenation

Delivery Choices Mouth piece Nasal mask Nasal prongs Face mask

Delivery Volume ventilation Pressure support Bilevel positive airway pressure (BiPAP) Proportional-assist ventilation (PAV) Continuous positive airway pressure (CPAP) Oxygen blended in for delivery of FiO2

CPAP Increases air pressure in airway to prevent airway collapse Single pressure setting during inhalation and exhalation Indicated for patients with OSA with positive sleep study Nasal Prongs

BiPAP Two pressure settings Higher pressure for inhalation (ipap) Lower pressure for exhalation (epap) Used when CPAP not effective Indicated with CO2 retention

Non-invasive Negative Pressure Cuirass shell Ventilation Vacuum device that lowers pressure surrounding the thorax Subatmospheric pressure passively expands the chest wall with descent of diaphragm Lung inflation Exhalation = passive recoil

Cuirass Shell

Patient Population Initially: Only polio patients Current Usage: Acute and Chronic respiratory failure Neuromuscular respiratory failure

Indications for Use Patient cooperation (an essential component that excludes agitated, belligerent, or comatose patients) Dyspnea (moderate to severe, but short of respiratory failure) Tachypnea (>24 breaths/min) Increased work of breathing (accessory muscle use, pursed-lips breathing) Hypercapnic respiratory acidosis (ph range 7.10-7.35) Hypoxemia (PaO 2 /FIO 2 < 200 mm Hg, most effective in rapidly reversible causes of hypoxemia)

Suitable Clinical Conditions for NIV ***COPD ***Cardiogenic pulmonary edema *Following d/c of mechanical ventilation (COPD) *Community-acquired pneumonia *Asthma *Immunocompromised state *Post-op respiratory distress and failure *DNR status *Neuromuscular respiratory failure *Decompensated OSA or Cor Pulmonale *Cystic Fibrosis *Mild Pneumocystic carinii pneumonia ***Most common

New Supplemental Oxygen Evidence: LOTT Trial New England Journal of Medicine October 2016 Vol. 375 (17) 47 centers participated Stable COPD, moderate resting desaturation (SpO2=89-93%) or moderate exercise-induced desaturation during 6MWT (SpO2 >80% for >5 min and <90% for >10 sec)

LOTT results No difference in giving supplemental O 2 for: -Time until death -Time until 1 st hospitalization -Time to 1 st COPD exacerbation -Changes in QOL, depression, anxiety, functional status Long-Term oxygen therapy in patients with stable COPD and resting or exercise-induced moderate desaturation has no benefit with regard to the multiple outcomes measured